AVE0010
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVE0010, covering 2014-01-28 to 2014-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus [Phase 2]